Navidea Biopharmaceuticals (NAVB) 8-K Entry into a Material Definitive Agreement

Exhibit 10.2

SCHEDULE IDENTIFYING MATERIAL DIFFERENCES BETWEEN
AMENDED EMPLOYMENT AGREEMENTS
BETWEEN NEOPROBE CORPORATION AND
THE INDIVIDUALS LISTED BELOW

	Commencement						Amount of Severance
	Date	Term	2008 Base Salary		Amount of Severance		upon change of control
David C. Bupp	1/1/2007	36 months	$	325,000	$	426,250	Greater of: (a) 30 months salary; or (b) $802,500
Brent L. Larson	1/1/2007	24 months	$	177,000	$	177,000	$	354,000
Anthony K. Blair	1/1/2007	24 months	$	150,000	$	150,000	$	300,000

		Continuation of Benefits
	Continuation of Benefits	Upon Termination	Continuation of Benefits
	Upon Disability	Without Cause	Upon Change of Control
David C. Bupp	Longer of 24 months or the full unexpired Term of the Agreement	Longer of 36 months or the full unexpired Term of the Agreement	Longer of 36 months or the full unexpired Term of the Agreement
Brent L. Larson	Longer of 12 months or the full unexpired Term of the Agreement	12 months	Longer of 12 months or the full unexpired Term of the Agreement
Anthony K. Blair	Longer of 12 months or the full unexpired Term of the Agreement	Longer of 12 months or the full unexpired Term of the Agreement	Longer of 12 months or the full unexpired Term of the Agreement